What 8 Analyst Ratings Have To Say About Gilead Sciences
What 8 Analyst Ratings Have To Say About Gilead Sciences
分析師評級認爲吉利德科學的情況如下：
In the last three months, 8 analysts have published ratings on Gilead Sciences (NASDAQ:GILD), offering a diverse range of perspectives from bullish to bearish.
過去三個月中，有8個分析師對吉利德科學（納斯達克：GILD）進行了評級，提供了從看好到看淡的多元化觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $79.5, along with a high estimate of $105.00 and a low estimate of $69.00. A decline of 5.03% from the prior average price target is evident in the current average.
分析師提供更深入的見解，已建立12個月的價格目標，表明平均目標爲79.5美元，高估值爲105.00美元，低估值爲69.00美元。 當前的平均價格目標與之前相比下降了5.03％。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
A comprehensive examination of...
對吉利德...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。